{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:48:26Z","timestamp":1782409706620,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.avsg.2026.03.025","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:11:46Z","timestamp":1774462306000},"page":"395-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PCSK9 Inhibitors in Peripheral Arterial Disease: A Systematic Review"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6938-7505","authenticated-orcid":false,"given":"Lameeya Murtaza","family":"Bandukwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-6877","authenticated-orcid":false,"given":"Daniel","family":"Curley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkis","family":"Bontinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vangelis","family":"Bontinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Shalhoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2026.03.025_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00355-8","article-title":"Global burden of peripheral artery disease and its risk factors, 1990\u20132019: a systematic analysis for the global Burden of Disease Study 2019","volume":"11","author":"Kim","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.avsg.2026.03.025_bib2","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.03.025_bib3","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/17085381211043952","article-title":"Effects of lipid-lowering therapy on major adverse limb events in patients with peripheral arterial disease: a meta-analysis of randomized clinical trials","volume":"30","author":"Masson","year":"2022","journal-title":"Vascular"},{"key":"10.1016\/j.avsg.2026.03.025_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.03.025_bib5","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2026.03.025_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018338","article-title":"Long-Term effectiveness and safety of initiating Statin therapy after index revascularization in patients with peripheral arterial occlusive disease","volume":"9","author":"Peters","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2026.03.025_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor's choice -- European Society for vascular surgery (ESVS) 2024 Clinical Practice Guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2026.03.025_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v9.i2.76","article-title":"PCSK9 inhibitors: a new era of lipid lowering therapy","volume":"9","author":"Chaudhary","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/j.avsg.2026.03.025_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1024\/0301-1526\/a000689","article-title":"PCSK9 inhibition for LDL lowering and beyond - implications for patients with peripheral artery disease","volume":"47","author":"Gebauer","year":"2018","journal-title":"Vasa"},{"key":"10.1016\/j.avsg.2026.03.025_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.avsg.2026.03.025_bib11","first-page":"Cd011748","article-title":"PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease","volume":"4","author":"Schmidt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.avsg.2026.03.025_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2021.09.022","article-title":"Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: european Atherosclerosis Society\/European Society of Vascular Medicine Joint Statement","volume":"338","author":"Belch","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2026.03.025_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-Density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.03.025_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.5551\/jat.57653","article-title":"Effects of PCSK9 inhibitor on favorable limb outcomes in patients with chronic limb-threatening ischemia","volume":"28","author":"Sato","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.avsg.2026.03.025_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2023.04.020","article-title":"The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study)","volume":"55","author":"Clavijo","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.avsg.2026.03.025_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.carrev.2024.10.006","article-title":"Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study)","volume":"76","author":"Dhillon","year":"2025","journal-title":"Cardiovasc Revasc Med"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509626001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:23:44Z","timestamp":1782408224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509626001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"alternative-id":["S0890509626001883"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2026.03.025","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 Inhibitors in Peripheral Arterial Disease: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2026.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}